Sponsor Pipeline

Shanxi Province Cancer Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06637007 Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced… Sarcoma,Soft Tissue Recruiting
NCT07646145 Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to… Non-Muscle-Invasive Bladder Cancer (NMIBC) Recruiting
NCT06255704 A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With… Mantle Cell Lymphoma Not Yet Recruiting
Phase 1/2
NCT07486648 Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior… Lung Cancer (NSCLC) Not Yet Recruiting
Disease Areas
Mantle Cell Lymphoma (1) Sarcoma (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Bladder Cancer (1)
Get alerts when Shanxi Province Cancer Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free